Table 5.
Risk factors for death in adult patients after liver transplantation
| Risk factor | Survivors (n = 60) | Nonsurvivors (n=33) | p value |
|---|---|---|---|
| Age (yr) | 36.0 ± 1.3 | 33.0 ± 1.7 | |
| Sex (male/female) | 22/38 | 16/17 | |
| Previous infectiona | 16% | 22% | |
| Previous immunosuppressive therapya | 24% | 25% | |
| Ascitesa | 51% | 71% | <0.05 |
| Variceal bleedinga | 21% | 42% | |
| Hepatic encephalopathya | 24% | 58% | <0.05 |
| Total bilirubin level (mg/dl)b | 14.1 ± 1.7 | 25.8 ± 1.7 | <0.01 |
| Prothrombin time (secb) | 16.4 ± 1.8 | 16.2 ± 0.6 | |
| Total serum proteins (mg/dl)b | 7.1 ± 0.2 | 6.4 ± 0.2 | |
| Serum albumin (mg/dl)b | 3.3 ± 0.1 | 3.1 ± 0.1 | |
| Transferrin (μg/dl)b | 352 ± 13 | 328 ± 18 | |
| WBC count (cells/mm3)b | 6,882 ± 473 | 9,157 ± 1,068 | <0.05 |
| PMN leukocytes (cells/mm3) | 4,480 ± 306 | 6,497 ± 866 | <0.05 |
| Total lymphocyte count (cells/mm3)b | 1,248 ± 97 | 1,055 ± 171 | |
| Total T lymphocytes (cells/mm3)b | 613 ± 47 | 672 ± 114 | |
| Helper T lymphcytes (cells/mm3)b | 181 ± 20 | 211 ± 31 | |
| Suppressor T lymphocytes (cells/mm3)b | 429 ± 29 | 490 ± 80 | |
| Helper to suppressor T lymphocytes ratiob | 3.7 ± 0.3 | 2.3 ± 0.2 | <0.05 |
| IgG (mg/dl)b | 1,432 ± 82 | 1,567 ± 130 | |
| IgM (mg/dl)b | 311 ± 23 | 288 ± 38 | |
| IgA (mg/dl)b | 370 ± 29 | 340 ± 42 | |
| C′3 (mg/dl) | 120 ± 9 | 106 ± 11 | |
| C′4 (mg/dl) | 23 ± 2 | 19 ± 2 | |
| CH100b | 68 ± 6 | 45 ± 4 | |
| PFB (mg/dl) | 42 ± 4 | 30 ± 3 | |
| Plasma creatinine (mg/dl)b | 1.3 ± 0.2 | 2.7 ± 0.4 | <0.05 |
a
Between first complaint and transplantation.
b
Preoperative evaluation.